1. Home
  2. EBS vs MUA Comparison

EBS vs MUA Comparison

Compare EBS & MUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • MUA
  • Stock Information
  • Founded
  • EBS 1998
  • MUA 1993
  • Country
  • EBS United States
  • MUA United States
  • Employees
  • EBS N/A
  • MUA N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • MUA Investment Bankers/Brokers/Service
  • Sector
  • EBS Health Care
  • MUA Finance
  • Exchange
  • EBS Nasdaq
  • MUA Nasdaq
  • Market Cap
  • EBS 359.3M
  • MUA 407.1M
  • IPO Year
  • EBS 2006
  • MUA N/A
  • Fundamental
  • Price
  • EBS $8.15
  • MUA $11.79
  • Analyst Decision
  • EBS Strong Buy
  • MUA
  • Analyst Count
  • EBS 3
  • MUA 0
  • Target Price
  • EBS $14.33
  • MUA N/A
  • AVG Volume (30 Days)
  • EBS 1.0M
  • MUA 92.6K
  • Earning Date
  • EBS 11-05-2025
  • MUA 01-01-0001
  • Dividend Yield
  • EBS N/A
  • MUA 4.84%
  • EPS Growth
  • EBS N/A
  • MUA N/A
  • EPS
  • EBS 2.53
  • MUA N/A
  • Revenue
  • EBS $851,600,000.00
  • MUA N/A
  • Revenue This Year
  • EBS N/A
  • MUA N/A
  • Revenue Next Year
  • EBS $19.24
  • MUA N/A
  • P/E Ratio
  • EBS $3.22
  • MUA N/A
  • Revenue Growth
  • EBS N/A
  • MUA N/A
  • 52 Week Low
  • EBS $4.02
  • MUA $8.61
  • 52 Week High
  • EBS $12.73
  • MUA $11.43
  • Technical
  • Relative Strength Index (RSI)
  • EBS 51.40
  • MUA 89.24
  • Support Level
  • EBS $7.45
  • MUA $10.58
  • Resistance Level
  • EBS $8.62
  • MUA $10.74
  • Average True Range (ATR)
  • EBS 0.40
  • MUA 0.17
  • MACD
  • EBS -0.10
  • MUA 0.10
  • Stochastic Oscillator
  • EBS 38.46
  • MUA 100.00

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About MUA Blackrock MuniAssets Fund Inc

Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.

Share on Social Networks: